#AwaazMarkets | #biocon की मलेशिया और बंगलुरु यूनिट को 11 आपत्तियां मिली है | #usfda के आपत्तियां पर #biocon Biologics के DEPUTY CEO, Shreehas Tambe ने कहा कि जल्द से जल्द दिक्कतों को सुधारा जाएगा |
Share Market से जुड़ी हर छोटी या बड़ी खबर, चाहे हो Nifty में आए नए हाई या फिर, हो आपके के लिए स्टॉक्स पर राय, बिजनेस न्यूज हो या पॉलिटिकल न्यूज, कोरोनावायरस की न्यूज हो या फिर इलेक्शन, देखें CNBC Awaaz और रहे हर खबर से updated.
#biocon #cnbcawaazlive #cnbcawaazlive #aajkatajakhabar #businessnewslive #stockmarketlive #sharemarketlive
cnbc awaaz live,cnbc awaaz live streaming,cnbc awaaz live hindi,cnbc awaaz,live cnbc awaaz,cnbc,cnbc live,stock market cnbc awaaz,final trade cnbc awwaz live,final trade cnbc bazaar,cnbc awaaz stock pick,cnbc final trade,cnbc awaaz share market,cnbc awaaz intraday picks,cnbc final trade live,cnbc awaaz budget 2022 live,stock market cnbc awaaz, cnbc awaaz live,cnbc,share bazaar live, n18oc_business
CNBC Awaaz is India’s number one business channel and an undisputed leader in business news and information for the last ten years. Our channel aims to educate, inform and inspire consumers to go beyond limitations, with practical tips on personal finance, investing, technology, consumer goods and capital markets. Policymakers and business owners alike have grown to trust CNBC Awaaz as the most reliable source with its eye on India’s business climate. Our programming gives consumers a platform to make decisions with confidence.
Subscribe to the CNBC Awaaz YouTube channel here:
Follow CNBC Awaaz on Twitter:
Like us on our CNBC Awaaz Facebook page:
Website: